Practices urged to revaccinate patients after hepatitis B vaccine recall

Stock of Engerix B, GlaxoSmithKline's (GSK) hepatitis B vaccine, is being recalled because it was kept too cold during transport.

Photograph: UNP
Photograph: UNP

Healthcare professionals should contact all known patients and recall them for revaccination, the MHRA has said.

The vaccine’s exposure to ‘unacceptably low temperatures’ during distribution could render it ineffective, but the manufacturer is not aware of any other safety concerns.

The batch of 1.0ml pre-filled syringes (20 micrograms/ml) being recalled is coded AHBVB591BB and was first distributed on 9 March. Its expiry date is 28 February 2011. Unused stock of this batch should not be used, the MHRA has said.

GSK plans to contact all customers and make arrangements for collection and replacement of stock. Any adverse events should be reported to the GSK safety department on 0800 221 441. For general enquiries, recipients should contact GSK on 0808 100 9997.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus